Indapamida Ciclum

Indapamide, the active ingredient in Indapamida Ciclum, is a thiazide‑like diuretic presented as an oral tablet for systemic use. It is employed to lower elevated blood pressure in adults and to reduce fluid retention in patients with edema related to congestive heart failure, and improve cardiovascular outcomes.

GNH USA supplies Indapamida Ciclum as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance.

Indapamide is indicated for conditions within the cardiovascular and renal fluid‑balance pathways.

Hypertension: lowers systolic and diastolic blood pressure, helping to prevent cardiovascular complications. Edema associated with congestive heart failure: increases urinary excretion of sodium and water, reducing peripheral swelling and improving symptoms. Hypertension combined with other antihypertensive agents: can be added to existing therapy to achieve better blood pressure control when monotherapy is insufficient.

Indapamide may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dizziness - Increased urination - Electrolyte disturbances (especially low potassium) - Headache

Serious or Rare Side Effects: - Severe dehydration - Hyponatremia - Allergic reactions such as rash or anaphylaxis

When prescribing indapamide, clinicians should consider several precautionary measures to ensure safe use. - Monitor electrolytes: perform regular blood tests for sodium, potassium and chloride levels. - Assess renal function: check creatinine and eGFR before initiating therapy and periodically thereafter. - Use caution in patients with gout: the drug may increase serum uric acid. - Avoid in severe hepatic impairment: limited safety data are available. - Adjust dose in elderly patients: increased sensitivity to diuretic effects may occur. - Store at room temperature: keep in the original pack, protect from moisture.

Indapamide can interact with various medicines; some combinations should be avoided, while others require careful monitoring.

Major Interactions (Avoid): - Lithium: may increase lithium toxicity. - NSAIDs: can blunt the diuretic effect and reduce blood pressure control. - Cyclosporine: may enhance nephrotoxic risk.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: risk of excessive potassium changes. - Beta‑blockers: additive blood pressure‑lowering effect. - Antidiabetic agents: may potentiate hypoglycemia.